Guardant Health

Palo Alto, California — September 4, 2026 Guardant Health announced that the U.S. Food and Drug Administration (FDA) has...

PALO ALTO, Calif., Sept. 1, 2026 Guardant Health announced that its Shield blood test for colorectal cancer (CRC) screening...

PALO ALTO, Calif., July 28, 2026 Guardant Health, Inc. has launched a new colorectal cancer (CRC) awareness campaign featuring...

PALO ALTO, Calif., June 11, 2026 Guardant Health announced that the U.S. Food and Drug Administration (FDA) has approved...

PALO ALTO, Calif., May 4, 2026 Guardant Health, Inc. has received U.S. Food and Drug Administration (FDA) approval for...

PALO ALTO, CA — December 5, 2025 — Guardant Health announced it will present 14 abstracts at the 2025...